Viewing Study NCT05800756


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:50 PM
Study NCT ID: NCT05800756
Status: UNKNOWN
Last Update Posted: 2023-04-06
First Post: 2023-03-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer
Sponsor: Yantai Yuhuangding Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module